Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The importance of dose intensity in chemotherapy of metastatic breast cancer.

× No keyword cloud information.

121 in total

Review 1. Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors: Jan Buter; Herbert M Pinedo
Journal: Curr Oncol Rep Date: 2003-05 Impact factor: 5.075

Review 2. Pharmacology of anticancer drugs in the elderly population.

Authors: Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

Review 3. Systemic therapy of advanced breast cancer.

Authors: H T Mouridsen
Journal: Drugs Date: 1992 Impact factor: 9.546

Review 4. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?

Authors: D J Dodwell; E S de Campos; J A Radford
Journal: Drugs Date: 1992-07 Impact factor: 9.546

5. Selecting dose-intense drug combinations: metastatic breast cancer.

Authors: E L Korn; R Simon
Journal: Breast Cancer Res Treat Date: 1992-03 Impact factor: 4.872

Review 6. The concept of dose intensification in the treatment of neoplastic disease.

Authors: U B Wandl; N Niederle
Journal: Infection Date: 1992 Impact factor: 3.553

Review 7. Biological response modifiers in the management of patients with breast cancer.

Authors: D L Longo; L C Hartmann
Journal: Breast Cancer Res Treat Date: 1990-09 Impact factor: 4.872

8. A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer.

Authors: Ji-Youn Han; Dae Ho Lee; Sung Young Lee; Chun Gun Park; Hae Young Kim; Eun-A Kim; Sung Min Yoon; Hong Gi Lee; Jin Soo Lee
Journal: Med Oncol Date: 2005 Impact factor: 3.064

9. Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors: T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal: J Neurooncol Date: 1994 Impact factor: 4.130

10. Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma.

Authors: H B Newton; C L Newton
Journal: J Neurooncol Date: 1995 Impact factor: 4.130